ALTSCHULLER Susan 4
4 · ImmunoGen, Inc. · Filed Dec 27, 2022
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
ALTSCHULLER Susan
SVP and CFO
Transactions
- Award
Stock Option (Right to Buy)
2022-11-14+82,500→ 123,750 totalExercise: $4.74From: 2022-11-14Exp: 2030-07-20→ Common Stock (82,500 underlying) - Award
Stock Option (Right to Buy)
2022-05-20+41,250→ 41,250 totalExercise: $4.74From: 2022-05-20Exp: 2030-07-20→ Common Stock (41,250 underlying)
Footnotes (2)
- [F1]On July 20, 2020, the reporting person was granted an option to purchase 165,000 shares of common stock. The option vests in installments upon the satisfaction of certain performance criteria. On May 20, 2022, certain performance criteria were met, resulting in the vesting of 25% of the performance stock option award.
- [F2]On July 20, 2020, the reporting person was granted an option to purchase 165,000 shares of common stock. The option vests in installments upon the satisfaction of certain performance criteria. On November 14, 2022, certain performance criteria were met, resulting in the vesting of 50% of the performance stock option award.